Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy

Pharmacotherapy
Taleen V JerjianCindy L O'Bryant

Abstract

Antibody-drug conjugates (ADCs) combine highly specific monoclonal antibodies with potent cytotoxic drugs. Their synergy allows for targeted delivery of toxic drugs to cancer cells while sparing systemic exposure. In this review, we focus on the history and clinical applications of ADCs approved by the U.S. Food and Drug Administration (FDA) for the treatment of cancer and highlight new ADCs in the drug development pipeline. Three ADCs have received FDA approval thus far. Gemtuzumab ozogamicin, although withdrawn from the U.S. market, may still be an effective treatment modality in subsets of patients with acute myeloid leukemia. Brentuximab vedotin and ado-trastuzumab emtansine have shown improved efficacy and safety data compared with standard chemotherapy for the treatment of advanced lymphoma and breast cancer, respectively. With a number of ADCs with promising preliminary data in the clinical trial pipeline, cancer therapy is moving forward from traditional chemotherapy to targeted treatment modalities driven by the specificity of monoclonal antibodies and advancing biotechnology.

References

Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E L SieversUNKNOWN Mylotarg Study Group
Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Sep 16, 2004·Journal of the National Cancer Institute
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kam Fai TseWilliam J LaRochelle
Nov 14, 2006·Breast Cancer Research : BCR·Rita Nahta, Francisco J Esteva
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoph A RitterCarlos L Arteaga
Nov 18, 2008·Cancer Research·Gail D Lewis PhillipsMark X Sliwkowski
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·April A N RosePeter M Siegel
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anjali AdvaniLuis Fayad
Apr 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E KropHoward A Burris
Jul 2, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Janakiraman SubramanianRamaswamy Govindan
Nov 5, 2010·The New England Journal of Medicine·Anas YounesAndres Forero-Torres
Dec 15, 2010·Expert Opinion on Biological Therapy·Massimo Breccia, Francesco Lo-Coco
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan K BurnettKeith Wheatley
Oct 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beverly A Teicher, Ravi V J Chari
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesRobert Chen
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara ProAndrei Shustov
Jul 28, 2012·Lancet·Kate R ShanklandBarry W Hancock
Oct 2, 2012·The New England Journal of Medicine·Sunil VermaUNKNOWN EMILIA Study Group
Mar 29, 2013·Nature Reviews. Drug Discovery·Rachel S ZolotRyan P Million
May 30, 2013·American Society of Clinical Oncology Educational Book·Mark R Litzow
Jul 31, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sonali M SmithParameswaran N Hari
Aug 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Stephen Ornes
Sep 17, 2013·British Journal of Haematology·Mohamed A Kharfan-DabajaAmbuj Kumar
Oct 18, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vincent RibragBertrand Coiffier
Apr 11, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·Michael D DeVitaAdam M Petrich
Jul 11, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Robert ChenStephen J Forman

❮ Previous
Next ❯

Citations

Jun 18, 2016·Oxidative Medicine and Cellular Longevity·Shreesh OjhaMohanraj Rajesh
May 24, 2016·Immunology·Tom Y-H Wu
Mar 1, 2017·Molecular Pharmaceutics·Nazzareno DimasiChangshou Gao
May 19, 2017·Angewandte Chemie·Nicholas AnkenbruckAlexander Deiters
Jul 17, 2018·Journal of Drug Targeting·Daniel Cristian Ferreira SoaresMarli Luiza Tebaldi
Dec 20, 2017·Experimental Biology and Medicine·Christian FercherRoss T Barnard
Mar 2, 2019·Breast Cancer Research and Treatment·Els DeklerckElke O Kreps
Aug 1, 2019·Journal of Experimental & Clinical Cancer Research : CR·Lawrence H CheungMichael G Rosenblum
Sep 22, 2020·Minerva medica·MIchele GottardiClaudio Cerchione
May 27, 2020·Molecular Cancer Therapeutics·Céline NicolazziVéronique Blanc
Jun 23, 2019·Molecular Cancer Therapeutics·Giuseppe MerlinoMonica Binaschi
Jul 20, 2017·Advanced Drug Delivery Reviews·Saleh YazdaniJai Prakash
Dec 6, 2016·Advanced Drug Delivery Reviews·Zehra ElgundiVeysel Kayser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Revue médicale suisse
Isabel ChofflonNhu-Nam Tran Thang
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
LeeRon Shefet-Carasso, Itai Benhar
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Kate Traynor
© 2022 Meta ULC. All rights reserved